Director at the Innovative Genomics Institute, University of California, Berkeley, US.
Over the last fifteen years Prof. Corn has bridged academia and industry, working in therapeutic areas that include infectious disease, neurodegeneration, and cancer. He adopts an interdisciplinary approach to the determination of cellular mechanisms underlying human disease, with a particular interest in genome editing, DNA repair, and ubiquitin signaling. Prof. Corn is interested in new models for collaboration between academia and industry, mentoring at the interface of these two areas, and promoting entrepreneurship. His research aims to bring about the end of genetic disease through the development and application of next-generation genome editing technologies.